StonvexLoading…
StonvexStonvexStonvexCore line items from HUBS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.13B | $2.63B | $2.17B | $1.73B |
Operating Income | $7.38M | $-67.60M | $-200.93M | $-102.86M |
Net Income | $45.91M | $4.63M | $-164.51M | $-107.35M |
EPS (Diluted) | $0.86 | $0.09 | $-3.30 | $-2.23 |
Total Assets | $3.85B | $3.80B | $3.07B | $2.54B |
Total Liabilities | $1.79B | $1.89B | $1.74B | $1.55B |
Cash & Equivalents | $882.24M | $512.67M | $387.99M | $331.02M |
Free Cash Flow OCF − CapEx | $707.55M | $560.66M | $317.25M | $235.75M |
Shares Outstanding | 52.55M | 51.77M | 50.45M | 49.22M |